RxDoctor Payments Data

Kamini Shreedhar

Endocrinology, Diabetes & Metabolism · West Nyack, NYNPI 1073587325

Payments from drug & device makers

$8,754in general payments, 2019–2025

Across 456 payments — averaging $19.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$2K
  • Novo Nordisk$2K
  • Sanofi-aventis U.S. LLC$683
  • AbbVie$422
  • Boehringer Ingelheim$376
  • Amgen$308
  • plus $3K from 26 others

What the payments were for

  • Food & beverage$8,740100%
  • Education$140%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,754 in reported general payments places this provider in the 75th percentile of 804 endocrinology, diabetes & metabolism providers in New York.

See all endocrinology, diabetes & metabolism providers in New York

Other endocrinology, diabetes & metabolism in West Nyack

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →